Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Liraglutide Injection Market Growth 2022-2028

  • LP 4794563
  • 79 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Liraglutide Injection will have significant change from previous year. According to our (LP Information) latest study, the global Liraglutide Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Liraglutide Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Liraglutide Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Liraglutide Injection market, reaching US$ million by the year 2028. As for the Europe Liraglutide Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Liraglutide Injection players cover Novo Nordisk, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Adult Type 2 Diabetes

Type II

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Novo Nordisk

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Liraglutide Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Liraglutide Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Liraglutide Injection by Country/Region, 2017, 2022 & 2028

2.2 Liraglutide Injection Segment by Type

2.2.1 Adult Type 2 Diabetes

2.2.2 Type II

2.3 Liraglutide Injection Sales by Type

2.3.1 Global Liraglutide Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Liraglutide Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Liraglutide Injection Sale Price by Type (2017-2022)

2.4 Liraglutide Injection Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Liraglutide Injection Sales by Application

2.5.1 Global Liraglutide Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Liraglutide Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Liraglutide Injection Sale Price by Application (2017-2022)

3 Global Liraglutide Injection by Company

3.1 Global Liraglutide Injection Breakdown Data by Company

3.1.1 Global Liraglutide Injection Annual Sales by Company (2020-2022)

3.1.2 Global Liraglutide Injection Sales Market Share by Company (2020-2022)

3.2 Global Liraglutide Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Liraglutide Injection Revenue by Company (2020-2022)

3.2.2 Global Liraglutide Injection Revenue Market Share by Company (2020-2022)

3.3 Global Liraglutide Injection Sale Price by Company

3.4 Key Manufacturers Liraglutide Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Liraglutide Injection Product Location Distribution

3.4.2 Players Liraglutide Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Liraglutide Injection by Geographic Region

4.1 World Historic Liraglutide Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Liraglutide Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Liraglutide Injection Annual Revenue by Geographic Region

4.2 World Historic Liraglutide Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Liraglutide Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Liraglutide Injection Annual Revenue by Country/Region

4.3 Americas Liraglutide Injection Sales Growth

4.4 APAC Liraglutide Injection Sales Growth

4.5 Europe Liraglutide Injection Sales Growth

4.6 Middle East & Africa Liraglutide Injection Sales Growth

5 Americas

5.1 Americas Liraglutide Injection Sales by Country

5.1.1 Americas Liraglutide Injection Sales by Country (2017-2022)

5.1.2 Americas Liraglutide Injection Revenue by Country (2017-2022)

5.2 Americas Liraglutide Injection Sales by Type

5.3 Americas Liraglutide Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Liraglutide Injection Sales by Region

6.1.1 APAC Liraglutide Injection Sales by Region (2017-2022)

6.1.2 APAC Liraglutide Injection Revenue by Region (2017-2022)

6.2 APAC Liraglutide Injection Sales by Type

6.3 APAC Liraglutide Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Liraglutide Injection by Country

7.1.1 Europe Liraglutide Injection Sales by Country (2017-2022)

7.1.2 Europe Liraglutide Injection Revenue by Country (2017-2022)

7.2 Europe Liraglutide Injection Sales by Type

7.3 Europe Liraglutide Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Liraglutide Injection by Country

8.1.1 Middle East & Africa Liraglutide Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Liraglutide Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Liraglutide Injection Sales by Type

8.3 Middle East & Africa Liraglutide Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Liraglutide Injection

10.3 Manufacturing Process Analysis of Liraglutide Injection

10.4 Industry Chain Structure of Liraglutide Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Liraglutide Injection Distributors

11.3 Liraglutide Injection Customer

12 World Forecast Review for Liraglutide Injection by Geographic Region

12.1 Global Liraglutide Injection Market Size Forecast by Region

12.1.1 Global Liraglutide Injection Forecast by Region (2023-2028)

12.1.2 Global Liraglutide Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Liraglutide Injection Forecast by Type

12.7 Global Liraglutide Injection Forecast by Application

13 Key Players Analysis

13.1 Novo Nordisk

13.1.1 Novo Nordisk Company Information

13.1.2 Novo Nordisk Liraglutide Injection Product Offered

13.1.3 Novo Nordisk Liraglutide Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novo Nordisk Main Business Overview

13.1.5 Novo Nordisk Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Liraglutide Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Liraglutide Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Adult Type 2 Diabetes

Table 4. Major Players of Type II

Table 5. Global Liraglutide Injection Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Liraglutide Injection Sales Market Share by Type (2017-2022)

Table 7. Global Liraglutide Injection Revenue by Type (2017-2022) & ($ million)

Table 8. Global Liraglutide Injection Revenue Market Share by Type (2017-2022)

Table 9. Global Liraglutide Injection Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Liraglutide Injection Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Liraglutide Injection Sales Market Share by Application (2017-2022)

Table 12. Global Liraglutide Injection Revenue by Application (2017-2022)

Table 13. Global Liraglutide Injection Revenue Market Share by Application (2017-2022)

Table 14. Global Liraglutide Injection Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Liraglutide Injection Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Liraglutide Injection Sales Market Share by Company (2020-2022)

Table 17. Global Liraglutide Injection Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Liraglutide Injection Revenue Market Share by Company (2020-2022)

Table 19. Global Liraglutide Injection Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Liraglutide Injection Producing Area Distribution and Sales Area

Table 21. Players Liraglutide Injection Products Offered

Table 22. Liraglutide Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Liraglutide Injection Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Liraglutide Injection Sales Market Share Geographic Region (2017-2022)

Table 27. Global Liraglutide Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Liraglutide Injection Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Liraglutide Injection Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Liraglutide Injection Sales Market Share by Country/Region (2017-2022)

Table 31. Global Liraglutide Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Liraglutide Injection Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Liraglutide Injection Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Liraglutide Injection Sales Market Share by Country (2017-2022)

Table 35. Americas Liraglutide Injection Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Liraglutide Injection Revenue Market Share by Country (2017-2022)

Table 37. Americas Liraglutide Injection Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Liraglutide Injection Sales Market Share by Type (2017-2022)

Table 39. Americas Liraglutide Injection Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Liraglutide Injection Sales Market Share by Application (2017-2022)

Table 41. APAC Liraglutide Injection Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Liraglutide Injection Sales Market Share by Region (2017-2022)

Table 43. APAC Liraglutide Injection Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Liraglutide Injection Revenue Market Share by Region (2017-2022)

Table 45. APAC Liraglutide Injection Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Liraglutide Injection Sales Market Share by Type (2017-2022)

Table 47. APAC Liraglutide Injection Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Liraglutide Injection Sales Market Share by Application (2017-2022)

Table 49. Europe Liraglutide Injection Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Liraglutide Injection Sales Market Share by Country (2017-2022)

Table 51. Europe Liraglutide Injection Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Liraglutide Injection Revenue Market Share by Country (2017-2022)

Table 53. Europe Liraglutide Injection Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Liraglutide Injection Sales Market Share by Type (2017-2022)

Table 55. Europe Liraglutide Injection Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Liraglutide Injection Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Liraglutide Injection Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Liraglutide Injection Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Liraglutide Injection Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Liraglutide Injection Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Liraglutide Injection Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Liraglutide Injection Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Liraglutide Injection Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Liraglutide Injection Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Liraglutide Injection

Table 66. Key Market Challenges & Risks of Liraglutide Injection

Table 67. Key Industry Trends of Liraglutide Injection

Table 68. Liraglutide Injection Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Liraglutide Injection Distributors List

Table 71. Liraglutide Injection Customer List

Table 72. Global Liraglutide Injection Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Liraglutide Injection Sales Market Forecast by Region

Table 74. Global Liraglutide Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Liraglutide Injection Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Liraglutide Injection Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Liraglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Liraglutide Injection Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Liraglutide Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Liraglutide Injection Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Liraglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Liraglutide Injection Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Liraglutide Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Liraglutide Injection Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Liraglutide Injection Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Liraglutide Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Liraglutide Injection Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Liraglutide Injection Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Liraglutide Injection Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Liraglutide Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Liraglutide Injection Revenue Market Share Forecast by Application (2023-2028)

Table 92. Novo Nordisk Basic Information, Liraglutide Injection Manufacturing Base, Sales Area and Its Competitors

Table 93. Novo Nordisk Liraglutide Injection Product Offered

Table 94. Novo Nordisk Liraglutide Injection Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Novo Nordisk Main Business

Table 96. Novo Nordisk Latest Developments

List of Figures

Figure 1. Picture of Liraglutide Injection

Figure 2. Liraglutide Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Liraglutide Injection Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Liraglutide Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Liraglutide Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Adult Type 2 Diabetes

Figure 10. Product Picture of Type II

Figure 11. Global Liraglutide Injection Sales Market Share by Type in 2021

Figure 12. Global Liraglutide Injection Revenue Market Share by Type (2017-2022)

Figure 13. Liraglutide Injection Consumed in Hospital

Figure 14. Global Liraglutide Injection Market: Hospital (2017-2022) & (K Pcs)

Figure 15. Liraglutide Injection Consumed in Clinic

Figure 16. Global Liraglutide Injection Market: Clinic (2017-2022) & (K Pcs)

Figure 17. Global Liraglutide Injection Sales Market Share by Application (2017-2022)

Figure 18. Global Liraglutide Injection Revenue Market Share by Application in 2021

Figure 19. Liraglutide Injection Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Liraglutide Injection Revenue Market Share by Company in 2021

Figure 21. Global Liraglutide Injection Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Liraglutide Injection Revenue Market Share by Geographic Region in 2021

Figure 23. Global Liraglutide Injection Sales Market Share by Region (2017-2022)

Figure 24. Global Liraglutide Injection Revenue Market Share by Country/Region in 2021

Figure 25. Americas Liraglutide Injection Sales 2017-2022 (K Pcs)

Figure 26. Americas Liraglutide Injection Revenue 2017-2022 ($ Millions)

Figure 27. APAC Liraglutide Injection Sales 2017-2022 (K Pcs)

Figure 28. APAC Liraglutide Injection Revenue 2017-2022 ($ Millions)

Figure 29. Europe Liraglutide Injection Sales 2017-2022 (K Pcs)

Figure 30. Europe Liraglutide Injection Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Liraglutide Injection Sales 2017-2022 (K Pcs)

Figure 32. Middle East & Africa Liraglutide Injection Revenue 2017-2022 ($ Millions)

Figure 33. Americas Liraglutide Injection Sales Market Share by Country in 2021

Figure 34. Americas Liraglutide Injection Revenue Market Share by Country in 2021

Figure 35. United States Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Liraglutide Injection Sales Market Share by Region in 2021

Figure 40. APAC Liraglutide Injection Revenue Market Share by Regions in 2021

Figure 41. China Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Liraglutide Injection Sales Market Share by Country in 2021

Figure 48. Europe Liraglutide Injection Revenue Market Share by Country in 2021

Figure 49. Germany Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Liraglutide Injection Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Liraglutide Injection Revenue Market Share by Country in 2021

Figure 56. Egypt Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Liraglutide Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Liraglutide Injection in 2021

Figure 62. Manufacturing Process Analysis of Liraglutide Injection

Figure 63. Industry Chain Structure of Liraglutide Injection

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390